Tazemetostat HCl (EPZ-6438 HCl; EPZ6438; E-7438; Tazverik), the hychloride salt of Tazemetostat, is an orally bioactive and selective inhibitor of Enhancer of Zeste-Homolog 2 (EZH2) that has been approved for cancer treatment.

纯度：≥98%

CAS：1467052-84-1